Board of Directors


Rx&D has an effective and engaged Board of Directors that enables member companies to achieve common objectives.

Executive Committee/Officers

Mark Lievonen, President, Sanofi Pasteur Limited
First Vice-Chair
John Helou, President, Pfizer Canada Inc.
Second Vice Chair
Felipe Pastrana, General Manager, AbbVie Corporation
Michael Tremblay, President, Astellas Pharma Canada, Inc.
Member at Large
Immediate Past Chair
Chris Halyk, President, Janssen Inc.

Ronnie Miller, President & CEO, Hoffmann-La Roche Limited

President Russell Williams, Canada’s Research-Based Pharmaceutical Companies (Rx&D)


Mark Beaudet, Interim President & CEO, Paladin Labs Inc.

Elaine Campbell, President & CEO, AstraZeneca Canada Inc.

Dr. Thomas R. Cannell, President & Managing Director, Merck Canada Inc.

Patrick Cashman, President and General Manager, Lundbeck Canada Inc.

Mike Egli, President & CEO, Takeda Canada Inc.

Fréderic Fasano, Chief Executive Officer, Servier Canada Inc.

Gilles Gagnon, President & CEO, Ceapro Inc.

Barry Hayter, General Manager, Abbott Laboratories, Limited

Vince Lamanna, President, Novo Nordisk Canada Inc.

Craig Landau, President & CEO, Purdue Pharma

Christian Lauterbach, President & CEO, Bayer Inc.

Paul Lirette, President, GlaxoSmithKline Inc.

Lisa Matar, President & General Manager, Eli Lilly Canada inc.

Allison Rosental, General Manager, Otsuka Canada Pharmaceutical Inc. (OCPI)

Oliver Technow, President & General Manager, Eisai Limited

Revised: April 3, 2014